Abstract 3197: BI-907828, a novel and potent MDM2-p53 antagonist, acts synergistically in a triple combination with anti-PD-1 and anti-LAG-3 antibodies in syngeneic mouse models of cancer

2019 ◽  
Author(s):  
Dorothea Rudolph ◽  
Ulrike Weyer-Czernilofsky ◽  
Markus Reschke ◽  
Martina Sykora ◽  
Jörg Rinnenthal ◽  
...  
Keyword(s):  
Mouse Models ◽  
Triple Combination ◽  
Syngeneic Mouse ◽  
Mouse Models Of Cancer

Abstract A149: Evaluating immune contexture in syngeneic mouse models of cancer

2016 ◽  
Author(s):  
Sapna Yadavilli ◽  
Sabyasachi Bhattacharya ◽  
Ashleigh Hahn ◽  
Laura Seestaller-Wehr ◽  
David Kilian ◽  
...  
Keyword(s):  
Mouse Models ◽  
Syngeneic Mouse ◽  
Immune Contexture ◽  
Mouse Models Of Cancer

Abstract 4886: PEGylated recombinant hyaluronidase PH20 (PEGPH20) enhances checkpoint inhibitor efficacy in syngeneic mouse models of cancer

2016 ◽  
Author(s):  
Sanna Rosengren ◽  
Renee Clift ◽  
Susan J. Zimmerman ◽  
Jennifer Souratha ◽  
Benjamin J. Thompson ◽  
...  
Keyword(s):  
Mouse Models ◽  
Checkpoint Inhibitor ◽  
Syngeneic Mouse ◽  
Mouse Models Of Cancer

OC-0282 Inhibition of oxidative phosphorylation alters the tumor microenvironment in syngeneic mouse models

2021 ◽  
Vol 161 ◽  
pp. S191-S192
Author(s):  
D. Boreel ◽  
P. Span ◽  
A. Kip ◽  
H. Peters ◽  
R. van den Bijgaart ◽  
...  
Keyword(s):  
Tumor Microenvironment ◽  
Oxidative Phosphorylation ◽  
Mouse Models ◽  
Syngeneic Mouse

scholarly journals Rapid Validation of Cancer Genes and Drug Targets in Genetically Engineered Mouse Models of Cancer

2013 ◽  
Vol 24 ◽  
pp. i7
Author(s):  
I.J. Huijbers ◽  
R. Bin Ali ◽  
C. Pritchard ◽  
M. Cozijnsen ◽  
N. Proost ◽  
...  
Keyword(s):  
Mouse Models ◽  
Drug Targets ◽  
Genetically Engineered ◽  
Cancer Genes ◽  
Genetically Engineered Mouse Models ◽  
Mouse Models Of Cancer
Sign in / Sign up

Export Citation Format

Share Document